{
    "version": "1.0",
    "type": "rich",
    "width": "",
    "height": "",
    "title": "Føflekkreft: Immunterapien Opdivo og dansk eksperimentell kreftvaksine gir høy responsrate i tidligfasestudie",
    "url": "https://www.healthtalk.no/esmo-2020-kreftvaksine-legemidler-og-biotek/foflekkreft-immunterapien-opdivo-og-dansk-eksperimentell-kreftvaksine-gir-hoy-responsrate-i-tidligfasestudie/120968",
    "author_name": "healthtalk",
    "author_url": "https://www.healthtalk.no",
    "provider_name": "Labrador",
    "provider_url": "http://www.labradorcms.com/",
    "html": "<div class=\"labrador-cms-embed\" data-lab-style=\" dac-embed-full\" data-lab-content=\"full\" data-lab-id=\"120968\" data-lab-site=\"www.healthtalk.no\"><script async defer src=\"https://www.healthtalk.no/embed.js?v=335\"></script></div>"
}